HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation
Related Experiment Video
Updated: Jul 5, 2026
Isolation, Transfection, and Culture of Primary Human Monocytes
Published on: December 16, 2019
J E Fildes1, S M Shaw, A Mitsidou
1The Transplant Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, M23 9LT, UK. james.fildes@manchester.ac.uk
Insights
Statins alter monocyte populations after heart transplant, reducing classical and non-classical monocytes. Different statins selectively affect monocyte subsets, impacting immune responses post-transplantation.
Area of Science:
- Immunology
- Transplantation Medicine
- Pharmacology
Background:
- Monocytes are crucial for immune responses after solid organ transplantation, influencing cytokine secretion and differentiation into macrophages and dendritic cells.
- The immunomodulatory effects of statins on human monocytes post-heart transplantation remain largely uncharacterized.
- This study aimed to investigate the impact of statin therapy on the monocyte compartment in heart transplant recipients.
Purpose of the Study:
- To elucidate the effects of statin administration on the circulating monocyte repertoire in patients following heart transplantation.
- To assess changes in monocyte population size and surface marker expression in response to statin therapy.
- To compare the differential effects of Atorvastatin and Pravastatin on monocyte subsets.
Main Methods:
- Recruitment of 108 patients undergoing heart transplantation.
- Collection of clinical data from patient records.
- Determination of peripheral blood immunophenotype using flow cytometry, analyzing markers such as CD11c, CD14, CD16, CD49d, CD64, CD80, and CD195.
Main Results:
- Statin treatment was associated with a significant reduction in both classical and non-classical monocyte counts.
- Expression of CD64 (FcgammaRI) was downregulated, while CD49d (VLA-4) expression was upregulated on monocytes in statin-treated patients.
- Atorvastatin led to a greater decrease in classical monocytes, whereas Pravastatin resulted in a more pronounced reduction in non-classical monocytes.
Conclusions:
- Statin administration significantly alters the circulating monocyte profile after heart transplantation.
- Changes include modifications in monocyte population numbers and expression levels of FcgammaRI and VLA-4.
- Specific statins demonstrate selective effects on monocyte subsets, potentially influencing macrophage or dendritic cell regeneration.
Background:
Monocytes mediate immune responses following solid organ transplantation via cytokine secretion and differentiation to macrophage/dendritic cell lineages. To date, the pleiotropic immunomodulatory effect of statins on human monocytes following human heart transplantation has yet to be elucidated. This study was designed to assess the effects of statin administration on the monocyte repertoire.
Methods:
108 patients were recruited into the study. Clinical data were collected from patients' notes. Peripheral blood immunophenotype was determined via flow cytometry (using CD11c, CD14, CD16, CD49d, CD64, CD80 and CD195).
Results:
There were fewer circulating classical (p=0.0001) and non-classical (p=0.0013) monocytes in patients treated with a statin. CD64 expression was down-regulated (p=0.011 and p=0.049) whereas CD49d expression was up-regulated (p=0.004 and p=0.022) on classical and non-classical monocytes in this group. Patients receiving Atorvastatin had fewer circulating classical monocytes (p=0.001) compared to patients administered Pravastatin. Patients receiving Pravastatin had fewer circulating non-classical monocytes (p=0.029) compared to patients administered Atorvastatin.
Discussion:
Statin administration alters the circulating monocyte repertoire following heart transplantation, including population size, FcgammaRI and VLA-4 adhesion molecule expression. Furthermore, different statin treatments are associated with a selective depletion of macrophage or DC (re)generating monocytes.
